| Literature DB >> 32102469 |
Biliana Nikolova1, Georgi Antov1,2, Severina Semkova1, Iana Tsoneva1, Nelly Christova3, Lilyana Nacheva3, Proletina Kardaleva4, Silvia Angelova5, Ivanka Stoineva4, Juliana Ivanova2, Ivanina Vasileva2, Lyudmila Kabaivanova3.
Abstract
Isolation and characterization of new biologically active substances affecting cancer cells is an important issue of fundamental research in biomedicine. Trehalose lipid was isolated from Rhodococcus wratislaviensis strain and purified by liquid chromatography. The effect of trehalose lipid on cell viability and migration, together with colony forming assays, were performed on two breast cancer (MCF7-low metastatic; MDA-MB231-high metastatic) and one "normal" (MCF10A) cell lines. Molecular modeling that details the structure of the neutral and anionic form (more stable at physiological pH) of the tetraester was carried out. The tentative sizes of the hydrophilic (7.5 Å) and hydrophobic (12.5 Å) portions of the molecule were also determined. Thus, the used trehalose lipid is supposed to interact as a single molecule. The changes in morphology, adhesion, viability, migration, and the possibility of forming colonies in cancer cell lines induced after treatment with trehalose lipid were found to be dose and time dependent. Based on the theoretical calculations, a possible mechanism of action and membrane asymmetry between outer and inner monolayers of the bilayer resulting in endosome formation were suggested. Initial data suggest a mechanism of antitumor activity of the purified trehalose lipid and its potential for biomedical application.Entities:
Keywords: Rhodococcus wratislaviensis; anticancer activity; bacterial natural disaccharide; breast cancer; molecular modeling; trehalose tetraester
Year: 2020 PMID: 32102469 PMCID: PMC7077702 DOI: 10.3390/polym12020499
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Scheme 1Chemical structure of the Rhodococcus sp. trehalose lipid.
Figure 1Number of viable cells after treatment with trehalose lipids (TL) at different concentrations (10, 25, 50, 75, 100 µM), presented as a percentage of control (untreated) cells, analyzed by MTT assay. Presented in (A–C) results are respectively for: MDA–MB23, MCF7 cancer cells, and normal MCF10A cell line; black solid columns present data after 24 h incubation and the striped columns after 48 h. All data are means ±SD from three independent experiments. Statistical analysis: (i) All results are statistically significant versus controls at corresponding incubation time (p-value <0.05); (ii) All presented data from 24 h are statistically significant versus data from 48 h (p-value <0.01); (iii) Cancer lines versus Normal cells: all variations between data in (A) are significant versus data in (C): p-value <0.001 for both 24/24 and 48/48 h type comparison; all variations between data in (B) are significant versus data in (C): p-value <0.05 for 24/24 h and p-value <0.01 for 48/48 h comparison. (iv) Data from cancer cell lines’ comparison were calculated also as a statistically significant result (p-value <0.01 for both 24/24 and 48/48 h variations). (D) GraphPad data calculation of the half-maximal inhibitory concentration (IC50)—number of viable cells 48 h after treatment with TL in different concentrations, as a percentage of control (untreated) cells. Values are means ±SD from at least three independent experiments at triplet repetitions.
Figure 2(A) Wound closure rate of breast normal/cancer cells 24 h after treatment with subcytotoxic concentration TL (75 µM), analyzed by CytoSelect™—wound healing (WH) assay. Calculated wound area of MCF10A normal cells (green columns), high-metastatic MDA-MB231 cell line (red columns) and low-metastatic MCF7cell line (blue columns) are presented as a percent of initial wound area at the initial zero time. All data are the means ±SD from two independent experiments and three independent calculations via ImageJ software; *p < 0.05 versus MCF10A normal cells, ** p < 0.01 versus MCF10A normal cells; # p < 0.05—all variations versus corresponding controls are statistically significant. (B) Cell migration capacity of normal MCF10A cells (top panel) and cancer cells (high-metastatic MDA-MB231 cells—middle panel; low-metastatic MCF7 cells—bottom panel) after treatment with subcytotoxic concentration (WH assay). Images were obtained after 24 h incubation by phase-contrast microscopy, magnification 10×.
Figure 3(A) Clonogenicity of normal MCF10A cells (top panel) and cancer cells (MDA-MB231 cells—middle panel; MCF7 cells—bottom panel) after long-term treatment with subcytotoxic concentration TL concentration (75 µM), analyzed by colony forming cell (CFC) assay. Untreated cells were used as a control. (B) Total number formed colonies of MCF10A, MDA MB231, and MCF7 breast cell lines after long-term treatment with subcytotoxic TL concentration (75 µM). All data are the means ±SD from two independent experiments and three independent enumerations; **p < 0.01 versus MCF10A normal cells, *** p < 0.001 versus MCF10A normal cells; ### p < 0.001—high-metastatic versus low-metastatic cancer cell line.
Figure 4Optimized structure of TL. Molecular modeling was performed as described in the text.
Figure 5Two (neutral) molecules of TL are shown to depict possible molecular interactions between them. One molecule is presented with sticks for the sake of simplicity.